Giving patients a choice: Genentech RA auto-injector product approved in US
The US FDA has approved Genentech’s auto-injector formulation of Actemra, which the firm says offers an additional administration option for patients and caregivers.
The US FDA has approved Genentech’s auto-injector formulation of Actemra, which the firm says offers an additional administration option for patients and caregivers.
Innovate UK has awarded £1.5m to three co-winners to investigate continuous manufacturing for AAV production.
BIO EUROPE 2018
It is more difficult and time-intensive to develop a successful biotech in Europe than in the US, says CEO.